Inhibition of groups 1 and 2 CD1 molecules on human dendritic cells by Leishmania species

Parasite Immunology

Volumn 29, Issue 10, 2007, Pages 515-524

  Donovan, M J ^a   Jayakumar, A ^a,b   McDowell, M A ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD1; Dendritic cells; Leishmania

Indexed keywords

CD1 ANTIGEN; CD1B ANTIGEN; CD1C ANTIGEN; CD1D ANTIGEN; LIPOPHOSPHOGLYCAN; T6 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; HUMAN; HUMAN CELL; LEISHMANIA; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; MONOCYTE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKIN LEISHMANIASIS;

ANIMALS; ANTIGENS, CD1; DENDRITIC CELLS; DOWN-REGULATION; GLYCOSPHINGOLIPIDS; HUMANS; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; MONOCYTES; POLYSACCHARIDES;

LEISHMANIA DONOVANI; LEISHMANIA MAJOR;

EID: 34648834713     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2007.00970.x     Document Type: Article

References (40)

1. Choi CM Lerner EA. Leishmaniasis as an emerging infection. J Investig Dermatol Symp Proc 2001 6 : 175 182.
2. Spath GF, Garraway LA, Turco SJ Beverley SM. The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Proc Natl Acad Sci USA 2003 100 : 9536 9541.
3. Desjardins M Descoteaux A. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J Exp Med 1997 185 : 2061 2068.
4. Gantt KR, Goldman TL, McCormick ML, et al. Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J Immunol 2001 167 : 893 901.
5. Spath GF, Epstein L, Leader B, et al. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proc Natl Acad Sci USA 2000 97 : 9258 9263.
6. Turco SJ, Hull SR, Orlandi PA, et al. Structure of the major carbohydrate fragment of the Leishmania donovani lipophosphoglycan. Biochemistry 1987 26 : 6233 6238.
7. Ilg T, Etges R, Overath P, et al. Structure of Leishmania mexicana lipophosphoglycan. J Biol Chem 1992 267 : 6834 6840.
8. McConville MJ, Schnur LF, Jaffe C Schneider P. Structure of Leishmania lipophosphoglycan: inter- and intra-specific polymorphism in Old World species. Biochem J 1995 310 : 807 818.
9. McConville MJ, Thomas-Oates JE, Ferguson MA Homans SW. Structure of the lipophosphoglycan from Leishmania major. J Biol Chem 1990 265 : 19611 19623.
10. Descoteaux A, Matlashewski G Turco SJ. Inhibition of macrophage protein kinase C-mediated protein phosphorylation by Leishmania donovani lipophosphoglycan. J Immunol 1992 149 : 3008 3015.
11. Descoteaux A, Turco SJ, Sacks DL Matlashewski G. Leishmania donovani lipophosphoglycan selectively inhibits signal transduction in macrophages. J Immunol 1991 146 : 2747 2753.
12. Proudfoot L, Nikolaev AV, Feng GJ, et al. Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proc Natl Acad Sci USA 1996 93 : 10984 10989.
13. de Veer MJ, Curtis JM, Baldwin TM, et al. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and toll-like receptor 2 signaling. Eur J Immunol 2003 33 : 2822 2831.
14. McDowell MA, Marovich M, Lira R, Braun M Sacks D. Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent. Infect Immun 2002 70 : 3994 4001.
15. Calabi F, Jarvis JM, Martin L Milstein C. Two classes of CD1 genes. Eur J Immunol 1989 19 : 285 292.
16. Porcelli SA Modlin RL. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol 1999 17 : 297 329.
17. Sieling PA, Chatterjee D, Porcelli SA, et al. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 1995 269 : 227 230.
18. Moody DB, Ulrichs T, Muhlecker W, et al. CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 2000 404 : 884 888.
19. Nakagawa H, Kobayashi H, Koezuka M, et al. [Chemotherapy for metastatic brain tumors with CDDP and other agents: correlation between chemotherapeutic effects and the results of in vitro chemosensitivity tests using collagen gel-embedded culture combined with computerized image analysis in metastatic brain tumors]. No Shinkei Geka 1994 22 : 517 523.
20. Amprey JL, Im JS, Turco SJ, et al. A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J Exp Med 2004 200 : 895 904.
21. Amprey JL, Spath GF Porcelli SA. Inhibition of CD1 expression in human dendritic cells during intracellular infection with Leishmania donovani. Infect Immun 2004 72 : 589 592.
22. Spath GF Beverley SM. A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp Parasitol 2001 99 : 97 103.
23. Donovan MJ, Messmore AS, Scrafford DA, Sacks DL, Kamhawi S McDowell MA. Uninfected mosquito bites confer protection against infection with malaria parasites. Infect Immun 2007 75 : 2523 2530.
24. Chaussabel D, Semnani RT, McDowell MA, Sacks D, Sher A Nutman TB. Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood 2003 102 : 672 681.
25. Mariotti S, Teloni R, Iona E, et al. Mycobacterium tuberculosis subverts the differentiation of human monocytes into dendritic cells. Eur J Immunol 2002 32 : 3050 3058.
26. Kanan JH Chain BM. Modulation of dendritic cell differentiation and cytokine secretion by the hydatid cyst fluid of Echinococcus granulosus. Immunology 2006 118 : 271 278.
27. Sugita M, Grant EP, van Donselaar E, et al. Separate pathways for antigen presentation by CD1 molecules. Immunity 1999 11 : 743 752.
28. Sugita M, Peters PJ Brenner MB. Pathways for lipid antigen presentation by CD1 molecules: nowhere for intracellular pathogens to hide. Traffic 2000 1 : 295 300.
29. Marovich MA, McDowell MA, Thomas EK Nutman TB. IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process. J Immunol 2000 164 : 5858 5865.
30. Roura-Mir C, Wang L, Cheng TY, et al. Mycobacterium tuberculosis regulates CD1 antigen presentation pathways through TLR-2. J Immunol 2005 175 : 1758 1766.
31. De Almeida MC, Cardoso SA Barral-Netto M. Leishmania (Leishmania) chagasi infection alters the expression of cell adhesion and costimulatory molecules on human monocyte and macrophage. Int J Parasitol 2003 33 : 153 162.
32. Yue SC, Shaulov A, Wang R, Balk SP Exley MA. CD1d ligation on human monocytes directly signals rapid NF-κB activation and production of bioactive IL-12. Proc Natl Acad Sci USA 2005 102 : 11811 11816.
33. Calabi F Milstein C. The molecular biology of CD1. Semin Immunol 2000 12 : 503 509.
34. Colmone A, Li S Wang CR. Activating transcription factor/cAMP response element binding protein family member regulated transcription of CD1A. J Immunol 2006 177 : 7024 7032.
35. Chen QY Jackson N. Human CD1D gene has TATA boxless dual promoters: an SP1-binding element determines the function of the proximal promoter. J Immunol 2004 172 : 5512 5521.
36. Yang Z, Mosser DM Zhang X. Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages. J Immunol 2007 178 : 1077 1085.
37. Prete SP, Giuliani A, D'Atri S, et al. BCG-infected adherent mononuclear cells release cytokines that regulate group 1 CD1 molecule expression. Int Immunopharmacol 2007 7 : 321 332.
38. Prete SP, Giuliani A, Iona E, et al. Bacillus Calmette-Guerin down-regulates CD1b induction by granulocyte-macrophage colony stimulating factor in human peripheral blood monocytes. J Chemother 2001 13 : 52 58.
39. Di Renzo M, Pasqui AL, Rubegni P, et al. Inhibition of maturation of human monocyte-derived dendritic cells in a patient with Mycobacterium avium infection. Int J Immunopathol Pharmacol 2006 19 : 391 397.
40. Mattner J, Donhavser N, Werner-Felmayer G Bogdan C. NKT cells mediate organ-specific resistance against Leishmania major infection. Microb Infect 2006 8 : 354 362.